While they found no significant difference in TIL infiltration between IBC and non-IBC tumors in the luminal and triple-negative subgroups, HER2-enriched IBC tumors had increased TILs compared to HER2-enriched, non-IBC tumors [33]. Here, ERBB2 is linked to inflammatory breast carcinoma.